Recombinant PDCD1 (Camrelizumab Biosimilar) antibody

Catalog No. ABIN7581612

This Human Monoclonal antibody specifically detects PDCD1 (Camrelizumab Biosimilar) in ELISA, BLI, FACS, Func and SPR. It exhibits reactivity toward Human.

Quick Overview for Recombinant PDCD1 (Camrelizumab Biosimilar) antibody (ABIN7581612)

Target: PDCD1 (Camrelizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This PDCD1 (Camrelizumab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-PDCD1 (Camrelizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-PDCD1 / PD-1 / CD279 Reference Antibody (camrelizumab)

Characteristics: Anti-PDCD1 / PD-1 / CD279 Reference Antibody (camrelizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for PDCD1 (Camrelizumab Biosimilar)

Target: PDCD1 (Camrelizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q15116